Management of secondary hyperparathyroidism in the elderly patient with chronic kidney disease. (Q37547201)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19591520 AND SRC:MED&resulttype=core&format=json

2 February 2020

review article

1 reference

title

Management of secondary hyperparathyroidism in the elderly patient with chronic kidney disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19591520 AND SRC:MED&resulttype=core&format=json

2 February 2020

1 reference

secondary hyperparathyroidism

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19591520 AND SRC:MED&resulttype=core&format=json

2 February 2020

Maurizio Gallieni

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19591520 AND SRC:MED&resulttype=core&format=json

2 February 2020

author name string

Sabina Pasho

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19591520 AND SRC:MED&resulttype=core&format=json

2 February 2020

Giuditta Fallabrino

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19591520 AND SRC:MED&resulttype=core&format=json

2 February 2020

Paola Ciceri

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19591520 AND SRC:MED&resulttype=core&format=json

2 February 2020

Elisa Maria Volpi

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19591520 AND SRC:MED&resulttype=core&format=json

2 February 2020

Laura Olivi

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19591520 AND SRC:MED&resulttype=core&format=json

2 February 2020

Diego Brancaccio

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19591520 AND SRC:MED&resulttype=core&format=json

2 February 2020

publication date

1 January 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19591520 AND SRC:MED&resulttype=core&format=json

2 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19591520 AND SRC:MED&resulttype=core&format=json

2 February 2020

volume

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19591520 AND SRC:MED&resulttype=core&format=json

2 February 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19591520 AND SRC:MED&resulttype=core&format=json

2 February 2020

page(s)

457-468

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19591520 AND SRC:MED&resulttype=core&format=json

What does serum fibroblast growth factor 23 do in hemodialysis patients?

2 February 2020

cites work

1 reference

12 December 2020

Cinacalcet reduces the set point of the PTH-calcium curve

1 reference

12 December 2020

Secondary hyperparathyroidism in patients from Western Australia with hip fracture: relationship to type of hip fracture, renal function, and vitamin D deficiency

1 reference

12 December 2020

Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications

1 reference

12 December 2020

Protein intake, control of serum phosphorus, and relatively low levels of parathyroid hormone in elderly hemodialysis patients.

1 reference

12 December 2020

Differential effects of 19-nor-1,25-(OH)(2)D(2) and 1alpha-hydroxyvitamin D(2) on calcium and phosphorus in normal and uremic rats

1 reference

12 December 2020

19-Nor-1-alpha-25-dihydroxyvitamin D2 (Paricalcitol) safely and effectively reduces the levels of intact parathyroid hormone in patients on hemodialysis

1 reference

12 December 2020

More than 1,000 cases of total parathyroidectomy with forearm autograft for renal hyperparathyroidism.

1 reference

12 December 2020

Efficacy of percutaneous ethanol injection therapy (PEIT) is related to the number of parathyroid glands in haemodialysis patients with secondary hyperparathyroidism

1 reference

12 December 2020

K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease

1 reference

12 December 2020

A new analog of 1,25-(OH)2D3, 19-NOR-1,25-(OH)2D2, suppresses serum PTH and parathyroid gland growth in uremic rats without elevation of intestinal vitamin D receptor content

1 reference

12 December 2020

The validity of a telephone-administered 24-hour dietary recall methodology

1 reference

12 December 2020

Effects of sevelamer and calcium-based phosphate binders on mortality in hemodialysis patients

1 reference

12 December 2020

A 1-year randomized trial of calcium acetate versus sevelamer on progression of coronary artery calcification in hemodialysis patients with comparable lipid control: the Calcium Acetate Renagel Evaluation-2 (CARE-2) study

1 reference

12 December 2020

Reduction of functioning parathyroid cell mass by ethanol injection in chronic dialysis patients.

1 reference

12 December 2020

Antirachitic Activity of 1α-Hydroxyergocalciferol and 1α-Hydroxycholecalciferol in Rats

1 reference

12 December 2020

The mechanism for the disparate actions of calcitriol and 22-oxacalcitriol in the intestine

1 reference

12 December 2020

Parathyroid hormone decreases renal vitamin D receptor expression in vivo

1 reference

12 December 2020

Lanthanum carbonate decreases PTH gene expression with no hepatotoxicity in uraemic rats.

1 reference

12 December 2020

The roles of calcium and 1,25-dihydroxyvitamin D3 in the regulation of vitamin D receptor expression by rat parathyroid glands

1 reference

12 December 2020

Vitamin D status and sex hormone binding globulin: determinants of bone turnover and bone mineral density in elderly women

1 reference

12 December 2020

Effects of excess PTH on nonclassical target organs

1 reference

12 December 2020

Incidence and risk factors for hip or other bone fractures among hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study.

1 reference

12 December 2020

Rat calcium-sensing receptor is regulated by vitamin D but not by calcium

1 reference

12 December 2020

The OPTIMA study: assessing a new cinacalcet (Sensipar/Mimpara) treatment algorithm for secondary hyperparathyroidism

1 reference

12 December 2020

Association of elevated serum PO(4), Ca x PO(4) product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients

1 reference

12 December 2020

Meta-analysis: vitamin D compounds in chronic kidney disease

1 reference

12 December 2020

The Effect of Vitamin D Supplementation on Vitamin D Status and Parathyroid Function in Elderly Subjects*

1 reference

12 December 2020

Pathophysiology and recent advances in the management of renal osteodystrophy

1 reference

12 December 2020

Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO)

1 reference

12 December 2020

A randomized, double-blind, crossover design study of sevelamer hydrochloride and sevelamer carbonate in patients on hemodialysis.

1 reference

12 December 2020

Transient decrease of serum bicarbonate levels with Sevelamer hydrochloride as the phosphate binder

1 reference

12 December 2020

Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis

1 reference

12 December 2020

Randomized, double-blind, placebo-controlled, dose-titration, phase III study assessing the efficacy and tolerability of lanthanum carbonate: a new phosphate binder for the treatment of hyperphosphatemia

1 reference

12 December 2020

Differential effects of vitamin D receptor activators on vascular calcification in uremic rats

1 reference

12 December 2020

1,25(OH)2 vitamin D3 inhibits parathyroid cell proliferation in experimental uremia

1 reference

12 December 2020

Predictors and consequences of altered mineral metabolism: the Dialysis Outcomes and Practice Patterns Study

1 reference

12 December 2020

Pathogenesis and treatment of secondary hyperparathyroidism in dialysis patients: the role of paricalcitol

1 reference

12 December 2020

Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease

1 reference

12 December 2020

Sevelamer reduces calcium load and maintains a low calcium-phosphorus ion product in dialysis patients

1 reference

12 December 2020

Effect of 18 months of treatment with alfacalcidol on bone in patients with mild to moderate chronic renal failure

1 reference

12 December 2020

Bone mineral density and biochemical markers of bone turnover in patients with predialysis chronic renal failure

1 reference

12 December 2020

Pathogenesis of vascular calcification in chronic kidney disease.

1 reference

12 December 2020

Seasonal variation of biochemical indexes of bone turnover: results of a population-based study

1 reference

12 December 2020

Efficacy and tolerability of sevelamer carbonate in hyperphosphatemic patients who have chronic kidney disease and are not on dialysis

1 reference

12 December 2020

Long-term efficacy and safety profile of lanthanum carbonate: results for up to 6 years of treatment

1 reference

12 December 2020

Effects of age and estrogen status on serum parathyroid hormone levels and biochemical markers of bone turnover in women: a population-based study

1 reference

12 December 2020

Serum osteocalcin is increased in patients with osteomalacia: correlations with biochemical and histomorphometric findings

1 reference

12 December 2020

Percutaneous maxacalcitol injection therapy regresses hyperplasia of parathyroid and induces apoptosis in uremia

1 reference

12 December 2020

Calcium receptor and regulation of parathyroid hormone secretion

1 reference

12 December 2020

Pathogenesis of parathyroid hyperplasia in renal failure.

1 reference

12 December 2020

Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients

1 reference

12 December 2020

Thinking straight about calcium

1 reference

12 December 2020

Paricalcitol-treated patients experience improved hospitalization outcomes compared with calcitriol-treated patients in real-world clinical settings

1 reference

12 December 2020

Vitamin D insufficiency and deficiency in chronic kidney disease. A single center observational study

1 reference

12 December 2020

Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy

1 reference

12 December 2020

Evolution of bone and plasma concentration of lanthanum in dialysis patients before, during 1 year of treatment with lanthanum carbonate and after 2 years of follow-up

1 reference

12 December 2020

Vitamin D insufficiency increases bone turnover markers and enhances bone loss at the hip in patients with established vertebral osteoporosis

1 reference

12 December 2020

Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis

1 reference

12 December 2020

Management of hyperphosphataemia in dialysis patients: role of phosphate binders in the elderly

1 reference

12 December 2020

Phosphate binders in uraemia: pharmacodynamics, pharmacoeconomics, pharmacoethics

1 reference

12 December 2020

A new analog of calcitriol, 19-nor-1,25-(OH)2D2, suppresses parathyroid hormone secretion in uremic rats in the absence of hypercalcemia

1 reference

12 December 2020

Cardiovascular calcifications in uremic patients: clinical impact on cardiovascular function

1 reference

12 December 2020

Long-term prognosis of parathyroid function for chronic dialysis patients after minimally invasive radioguided parathyroidectomy (MIRP).

1 reference

12 December 2020

Mineral metabolism, mortality, and morbidity in maintenance hemodialysis

1 reference

12 December 2020

Vascular calcification and uremia: what do we know?

1 reference

12 December 2020

Mortality effect of coronary calcification and phosphate binder choice in incident hemodialysis patients

1 reference

12 December 2020

Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxy-cholecalciferol in uremic patients

1 reference

12 December 2020

Differential effects of vitamin D analogs on vascular calcification

1 reference

12 December 2020

Preventive measures and new pharmacological approaches of calcium and phosphate disorders.

1 reference

12 December 2020

Paricalcitol versus calcitriol in the treatment of secondary hyperparathyroidism

1 reference

12 December 2020

Higher strength lanthanum carbonate provides serum phosphorus control with a low tablet burden and is preferred by patients and physicians: a multicenter study

1 reference

12 December 2020